Hypoxic LOX, LOXL2, and LOXL4 secretion by breast cancer cells results in collagen remodelling in lungs, which allows the recruitment of bone-marrow derived cells (BMDCs) to the area. This evidence concerns the gene LOX and breast carcinoma.